Tested Applications
| Positive WB detected in | human placenta tissue, human adrenal gland tissue |
| Positive IP detected in | mouse heart tissue |
| Positive IHC detected in | human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF-P detected in | human liver cancer tissue |
| Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:300-1:1500 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
12077-1-AP targets TINAGL1 in WB, IHC, IF/ICC, IF-P, IP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag2721 Product name: Recombinant human TINAGL1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-218 aa of BC009048 Sequence: MTPVLSPQNLLSCDTHQQQGCRGGRLDGAWWFLRRRGVVSDHCYPFSGRERDEAGPAPPCMMHSRAMGRGKRQATAHCPNSYVNNNDIYQVTPVYRLGSNDKEIMKELMENGPVQALMEVHEDFFLYKGGIYSHTPVSLGRPERYRRHGTHSVKITGWGEETLPDGRTLKYWTAANSWGPAWGERGHFRIVRGVNECDIESFVLGVWGRVGMEDMGHH Predict reactive species |
| Full Name | tubulointerstitial nephritis antigen-like 1 |
| Calculated Molecular Weight | 467 aa, 52 kDa |
| Observed Molecular Weight | 52 kDa |
| GenBank Accession Number | BC009048 |
| Gene Symbol | TINAGL1 |
| Gene ID (NCBI) | 64129 |
| RRID | AB_2058942 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9GZM7 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Tubulointerstitial nephritis antigen-like 1 (Tinagl1), a secreted extracellular protein, was initially identified as a putative component of the ECM. Tinagl1 is most commonly associated with embryonic development, including the heart and adrenal glands. Low levels of Tinagl1 expression can be dire for craniofacial development and for female fertility.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for TINAGL1 antibody 12077-1-AP | Download protocol |
| IHC protocol for TINAGL1 antibody 12077-1-AP | Download protocol |
| IP protocol for TINAGL1 antibody 12077-1-AP | Download protocol |
| WB protocol for TINAGL1 antibody 12077-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The TINAGL1 Polyclonal antibody (Cat# 12077-1-AP) has 10 total citations. These appear in journals including Cancer Cell, International Journal of Biological Sciences, Journal of Translational Medicine, Scientific Reports, Cell Signaling, BMC Complementary Medicine and Therapies, Biochimica et Biophysica Acta, FASEB Journal, Cancer Management and Research, and Matrix Biology Plus. Research fields span oncology (breast, gastric, esophageal, liver, and hepatocellular cancers), liver fibrosis, muscle development and remodeling, wound healing in diabetes, and inflammation/metabolism.
| Species | Application | Title |
|---|---|---|
Cancer Cell Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling. | ||
Int J Biol Sci Tubulointerstitial nephritis antigen-like 1 promotes the progression of liver fibrosis after HCV eradication with direct-acting antivirals | ||
J Transl Med Tubulointerstitial nephritis antigen-like 1 from cancer-associated fibroblasts contribute to the progression of diffuse-type gastric cancers through the interaction with integrin β1 | ||
Sci Rep Paracancerous binuclear hepatocytes assessed by computer program is a novel biomarker for short term recurrence of hepatocellular carcinoma after surgery | ||
Cell Signal YTHDF1 facilitates esophageal cancer progression via augmenting m6A-dependent TINAGL1 translation
| ||
BMC Complement Med Ther Anti-cancer effects of genistein supplementation and moderate-intensity exercise in high-fat diet-induced breast cancer via regulation of inflammation and adipose tissue metabolism in vivo and in vitro |
Reviews
What customers say
Able is busy answering your previous question. Please try again later.
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
Julia (Verified Customer) (07-24-2025) | Visible staining
|















